治疗性隐形眼镜市场按产品类型、应用、分销管道和地区划分

2024 年全球治疗性隐形眼镜市场规模估计为 49.1 亿美元，预计 2031 年将达到 79 亿美元，2024 年至 2031 年的复合年增长率为 7%。

图。

治疗性隐形眼镜是由眼科保健专家开立的特殊镜片，用于矫正视力和保持眼睛健康。这些镜片专门用于治疗屈光不正、散光、老花眼和各种眼表疾病。白内障、圆锥角膜、糖尿病视网膜病变等眼科疾病发生率的上升推动了对治疗性隐形眼镜的需求。此外，隐形眼镜材质的技术进步提供了卓越的舒适度和延长配戴时间的能力，进一步扩大了这些镜片的应用范围。然而，一些地区对可用的治疗方案缺乏认识，以及专业镜片的价格高昂，可能会在一定程度上抑制市场的成长。

市场动态：

全球治疗性隐形眼镜市场主要受老年人口不断增长的推动，老年人容易患上需要治疗的眼科疾病。根据世界卫生组织2024年10月预测，到2050年，全球整体65岁或以上人口将超过13亿人。此外，与文明病（如糖尿病）的发生率不断上升，从而导致糖尿病视网膜病变等疾病，这也推动了需求。此外，与传统镜片相比，硅胶水凝胶镜片具有更高的透氧渗透性，可延长配戴时间并提高患者的依从性，从而增加了市场采用率。然而，专用镜片成本高昂（特别是针对罕见疾病）以及新兴经济体对治疗方案缺乏认识，带来了重大挑战。此外，隐形眼镜製造的严格监管核准和基础设施要求也对新进业者构成了挑战。然而，随着应用领域的不断扩大和价格实惠的镜片的持续研发，预计未来几年将出现新的商机。

本研究的主要特点

本报告对全球治疗性隐形眼镜市场进行了详细分析，并展示了预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2023 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球治疗性隐形眼镜市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。

研究中涉及的主要企业包括强生公司、爱尔康、博士伦、库博光学、曼尼康株式会社、豪雅株式会社、卡尔蔡司公司、依视路陆逊梯卡、SynergEyes 公司、OptiMed 技术公司、Aerie 製药公司、Eyevance 製药公司、Ocular Therapeutix 技术公司、Visione-Ctel-Btel-Coerings Xt。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球治疗性隐形眼镜市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过用于分析全球治疗性隐形眼镜市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• PORTER 分析
• 併购情景
• 产业趋势

4. 全球治疗性隐形眼镜市场（依产品类型），2019 年至 2031 年

• 软式镜片
• 硬镜片
• 专业镜头

5. 全球治疗性隐形眼镜市场（依应用划分），2019 年至 2031 年

• 眼科手术后
• 角膜疾病
• 药物输送
• 其他的

6. 全球治疗性隐形眼镜市场，依通路划分，2019-2031 年

• 零售药局
• 医院药房
• 网路药局

7. 2019 年至 2031 年全球治疗性隐形眼镜市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• Johnson & Johnson
• Alcon
• Bausch+Lomb
• CooperVision
• Menicon Co., Ltd.
• Hoya Corporation
• Carl Zeiss AG
• EssilorLuxottica
• SynergEyes, Inc.
• OptiMed Technology, Inc.
• Aerie Pharmaceuticals, Inc.
• Eyevance Pharmaceuticals
• Ocular Therapeutix, Inc.
• Visioneering Technologies, Inc.
• X-Cel Specialty Contacts

第 9 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

The global therapeutic contact lenses market is estimated to be valued at USD 4.91 Bn in 2024 and is expected to reach USD 7.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.

Figure. Therapeutic Contact Lenses Market Share (%), By Region 2024

Therapeutic contact lenses are specialized lenses prescribed by eye care professionals to support vision correction and eye health. These lenses are designed to treat refractive errors, astigmatism, presbyopia, and various ocular surface diseases. The rising incidence of ocular disorders such as cataract, keratoconus, and diabetic retinopathy has been driving the demand for therapeutic contact lenses. Additionally, technological advancements in contact lens materials that offer superior comfort and extended wear capabilities are further widening the application scope of these lenses. However, lack of awareness about available treatment options and high cost of specialized lenses in some regions may restrain the market growth to some extent.

Market Dynamics:

The global therapeutic contact lenses market is primarily driven by the growing geriatric population which is more susceptible to ocular diseases requiring treatment. According to the WHO, in October 2024, estimates reveal over 1.3 billion people globally will be aged 65 years or older by 2050. Additionally, rising prevalence of lifestyle diseases such as diabetes propelling conditions like diabetic retinopathy is also fueling the demand. The market is also witnessing increasing adoption of silicone hydrogel lenses owing to their enhanced oxygen permeability compared to conventional lenses, allowing extended wear periods and better patient compliance. However, high cost of specialty lenses particularly for rare conditions and lack of awareness about treatment options in developing economies are major challenges. Moreover, stringent regulatory approvals and infrastructure requirements for contact lenses manufacturing pose difficulties for new entrants. Nevertheless, ongoing R&D to expand applications and develop affordable lenses presents new opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global therapeutic contact lenses market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global therapeutic contact lenses market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson, Alcon, Bausch + Lomb, CooperVision, Menicon Co., Ltd., Hoya Corporation, Carl Zeiss AG, EssilorLuxottica, SynergEyes, Inc., OptiMed Technology, Inc., Aerie Pharmaceuticals, Inc., Eyevance Pharmaceuticals, Ocular Therapeutix, Inc., Visioneering Technologies, Inc., and X-Cel Specialty Contacts

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global therapeutic contact lenses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic contact lenses market

Market Segmentation

• By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Soft Lenses
  • Rigid Lenses
  • Specialty Lenses
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Post-Ocular Surgery
  • Corneal Disorders
  • Drug Delivery
  • Others
• By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Retail Pharmacies
  • Hospitals Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson
  • Alcon
  • Bausch + Lomb
  • CooperVision
  • Menicon Co., Ltd.
  • Hoya Corporation
  • Carl Zeiss AG
  • EssilorLuxottica
  • SynergEyes, Inc.
  • OptiMed Technology, Inc.
  • Aerie Pharmaceuticals, Inc.
  • Eyevance Pharmaceuticals
  • Ocular Therapeutix, Inc.
  • Visioneering Technologies, Inc.
  • X-Cel Specialty Contacts

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Therapeutic Contact Lenses Market, By Product Type
  • Global Therapeutic Contact Lenses Market, By Application
  • Global Therapeutic Contact Lenses Market, By Distribution Channel
  • Global Therapeutic Contact Lenses Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Therapeutic Contact Lenses Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Soft Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Rigid Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Therapeutic Contact Lenses Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Post-Ocular Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Corneal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Therapeutic Contact Lenses Market, By Distribution Channel, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Therapeutic Contact Lenses Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive landscape

• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alcon
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bausch + Lomb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperVision
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Menicon Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hoya Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carl Zeiss AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EssilorLuxottica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SynergEyes, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OptiMed Technology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aerie Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eyevance Pharmaceuticals
• Ocular Therapeutix, Inc.
• Visioneering Technologies, Inc.
• X-Cel Specialty Contacts

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us